Drug Trial Radar · NCT04717310
Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Sep 5, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
645
Actual
Start
Dec 30, 2020
Primary completion
Sep 8, 2023
Study completion Jul 14, 2024
Sponsor
- Lead sponsor
- Reistone Biopharma Company LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jan 22, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Randomized, Double-blind, Vehicle-Controlled, Seamless and Adaptive-designed Phase II/III Study to Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Adult Patients with Mild-to-Moderate Atopic Dermatitis. It will consist of phase II and phase III parts, phase II will be a dose-ranging part and phase III will be a pivotal study part.
Conditions
- Atopic Dermatitis
Interventions
SHR0302 OintmentDrug
SHR0302 Ointment Twice a day (BID)
SHR0302 OintmentDrug
SHR0302 Ointment Twice a day (BID)
SHR0302 OintmentDrug
SHR0302 Ointment Twice a day (BID)
VehicleDrug
Twice a day (BID)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change from baseline in the eczema area and severity index (EASI) total score at Week 8Time frame: 8 weeks
Locations
31 sites in 1 country. Site status is shown where the registry gives one.
The Third Xiangya Hospital of Central South University
Changsha, China
Sun. Yat- Sen Memorial Hospital, Sun. Yat- Sen University
Guangzhou, China
Zhejiang province People's Hospital
Hangzhou, China
Huashan Hospital Fudan University
Shanghai, China
Anhui Provincial Hospital
Hefei, Anhui, China
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Beijing Hospital
Beijing, Beijing Municipality, China
Chongqing Traditional Chinese Medicine Hospital
Chongqing, Chongqing Municipality, China
The First Hospital Affiliated to AMU (Southwest Hospital)
Chongqing, Chongqing Municipality, China
Xinqiao Hospital of AMU
Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
The First Affiliated Hospital Sun Yat-sen University
Guangzhou, Guangdong, China
Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China
Nanyang first people's Hospital
Nanyang, Henan, China
Wuhan NO.1 Hospital
Wuhan, Hubei, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
The Second People's Hospital of Wuxi
Wuxi, Jiangsu, China
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, China
Jiangxi Provincial Hospital of Dermatology
Nanchang, Jiangxi, China
The Second Hospital of Jilin University
Changchun, Jilin, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Shanghai Skin Disease Hospital
Shanghai, Shanghai Municipality, China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, Tianjin Municipality, China
SIR RUN RUN Shaw Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China
Hangzhou Third People's Hospital
Hangzhou, Zhejiang, China
Hwa Mei Hospital
Ningbo, Zhejiang, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.